GLP-1 receptor agonist

Compounded
semaglutide.

Compounded semaglutide through licensed 503A compounding pharmacies — the same active compound as brand-name semaglutide, prescribed by licensed providers at a fraction of the brand-name cost.

We'll email you if compounded semaglutide access opens. No spam.

Sequence31 amino acids
Molecular weight4,113.58 g/mol
ReceptorGLP-1
AdministrationSC weekly
Compounded access

Why compounded semaglutide.

Brand-name semaglutide costs $1,000+/month and faces ongoing shortages. Compounded semaglutide delivers the same molecule at accessible pricing through licensed pharmacies.

01

Same active compound

Compounded semaglutide contains the identical 31-amino-acid peptide sequence as brand-name formulations. Prepared by licensed 503A compounding pharmacies under USP 797 sterile compounding standards.

02

503A compounding access

Licensed 503A compounding pharmacies can prepare patient-specific compounded semaglutide when a prescriber documents a clinical need that the commercially available product does not meet — such as custom dosing, allergen-free formulations, or alternative concentrations.

03

Fraction of brand-name cost

Brand-name semaglutide lists at $1,349/month. Compounded semaglutide from licensed pharmacies typically costs $150–$400/month — the same molecule, same clinical protocol, dramatically lower price.

Compounded vs brand

The honest comparison.

Compounded semaglutide is not a generic — it is a pharmacy-prepared version of the same active compound, available through licensed 503A pharmacies with a valid patient-specific prescription.

FeatureBrand-name semaglutideCompounded semaglutide
Active ingredientSemaglutideSemaglutide (identical)
AvailabilityLimited availabilityAvailability varies
Monthly cost$1,000–$1,349 (list price)$150–$400/month
Prescription requiredYesYes — physician-supervised
Pharmacy typeRetail pharmacyLicensed 503A compounding pharmacy
AdministrationPre-filled pen (weekly SC injection)Vial + syringe (weekly SC injection)
Dosing flexibilityFixed pen dosesCustom dose titration available
FDA statusFull NDA approvalCompounded under 503A with documented clinical need

Stay informed.

Enter your email to be notified if compounded semaglutide access opens.

We'll email you if compounded semaglutide access opens. No spam.